Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome

Pediatr Nephrol. 2022 May;37(5):927-931. doi: 10.1007/s00467-021-05345-9. Epub 2022 Jan 9.

Authors

Eugene Yu-Hin Chan¹, Alison Lap-Tak Ma², Kjell Tullus³

Affiliations

¹ Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong. eugene.chan@ha.org.hk.
² Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong.
³ Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Trust, London, UK.

PMID: 34999985
DOI: 10.1007/s00467-021-05345-9

No abstract available

Publication types

Editorial
Comment

MeSH terms

Agammaglobulinemia* / chemically induced
Female
Humans
Immunologic Factors / adverse effects
Male
Nephrotic Syndrome* / drug therapy
Recurrence
Rituximab / adverse effects
Treatment Outcome

Substances

Immunologic Factors
Rituximab